EuroSIDA Publications 2025

  1. Viremia does not independently predict cardiovascular disease in people with HIV: a RESPOND cohort study. Elvstam O, Ryom L, Neesgaard B, Tau L, Günthard H F, Zangerle R, Vehreschild J J, Wit F, Sönnerborg A, Kovari H, Abutidze A, Petoumenos K, Jaschinski J, Hosein S, Bogner J, Grabmeier-Pfistershammer K, Garges H, Rooney J, Young L, Law M, Kirk O for the RESPOND Study Group.
    Open Forum Infectious Diseases 2025. Jan 13;12(2):ofaf016. 
    Abstract
    ​

  2. Incident tuberculosis in people with HIV across Europe from 2012-2022: incidence rates, risk factors, and regional differences in a multicentre cohort study. Kraef C, Roen A, Podlekareva D, Bakowska E, Nemeth J, Knappik M, Payen M-C, Wit F, Mussini C, d’Arminio Monforte11 A, Castagna A, Chkhartishvili N, Neesgaard B, Jaschinski1 N, Volny Anne A, Borodulina E, Ballief M, Wallner E, Israelski D, Garges H, Mocroft A, Kirk O and the RESPOND Study Group. 
    European Respiratory Journal 2025. Feb 20:2401904. 
    Abstract
    ​

  3. Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohort. Han WM, Ryom L, Sabin C, Greenberg L, Cavassini M, Egle A, Duvivier C, Wit F, Mussini C, d'Arminio Monforte A, Castagna A, Miro JM, van der Valk M, Bonnet F, Pradier C, Skocic M, Matulionyte R, Stöckle M, Jaschinski N, Timiryasova A, Tallada J, Rogatto FP, Vannappagari V, Young LA, Lundgren JD, Petoumenos K, Hoy JF. 
    Clinical Infectious Diseases 2025. May 15:ciaf248.
    Abstract
    ​

  4. Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study. Tusch E, Ryom L, Hoffmann C, Degen O, Zangerle R, Günthard HF, Wit F, Mussini C, Castagna A, Martin C, Giacomelli A, Vehreschild JJ, Begovac J, Vannappagari V, Rooney J, Mendes SDS, Tallada J, Kowalska J, Wallner E, Kusejko K, Naschinski N, Lundgren J, Peters L, Reekie J.
    eClinicalMedicine 2025
    Abstract

Total number of publications: 349

In Press

  1. Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe. Lorin Begré, Anders Boyd, Marie-Laure Plissonnier, Barbara Testoni, Charles Béguelin, Franziska Suter-Riniker, Caroline Scholtès, Jürgen K. Rockstroh, Karine Lacombe, Lars Peters, Marintha Heil, Massimo Levrero, Andri Rauch, Fabien Zoulim, Gilles Wandeler for the Swiss HIV Cohort study, EuroSIDA and French HIV/HBV and Biliver cohorts.
    JHEP Reports.
    ​